ANDA 83021, held by Epic Pharma LLC. Sulfacetamide Sodium.
As of Nov 15, 2026, ANDA 83021 (Sodium Sulfacetamide), held by Epic Pharma LLC, was not approved, with 0 approved supplements and 0 published complete response letters.
| Sodium Sulfacetamide10% · solution/drops;ophthalmic | Sulfacetamide Sodium | Discontinued |
| Sodium Sulfacetamide15% · solution/drops;ophthalmic | Sulfacetamide Sodium | Discontinued |
| Sodium Sulfacetamide30% · solution/drops;ophthalmic | Sulfacetamide Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
